Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06712875
Title MAPK Inhibition Combined with Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Ann & Robert H Lurie Children's Hospital of Chicago
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST